Frédéric Amant
Impact in
- Obstetrics and Gynecology top 0.01%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments
- Reproductive Medicine top 0.02%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Endometrial and Cervical Cancer Treatments 181
- Uterine Myomas and Treatments 56
-
- Ovarian cancer diagnosis and treatment 129
- Co-authors
- Ignace B. Vergote (232 shared papers)Patrick Neven (90 shared papers)Dirk Timmerman (38 shared papers)Kristel Van Calsteren (102 shared papers)Philippe Moerman (52 shared papers)Karin Leunen (79 shared papers)Carien L. Creutzberg (9 shared papers)Mansoor Raza Mirza (7 shared papers)
- Journals
- International Journal of Gynecological Cancer (119 papers)Gynecologic Oncology (65 papers)Journal of Clinical Oncology (25 papers)Annals of Oncology (22 papers)European Journal of Cancer (22 papers)
- Partner nations
- BelgiumNetherlandsItaly
In The Last Decade
Frédéric Amant
649 papers receiving 32k citations
Frédéric Amant's Hit Papers
Peers
Comparison fields: 5 of 158
- Obstetrics and Gynecology 8.8k
- Reproductive Medicine 6.8k
- Cancer Research 3.9k
- Oncology 5.5k
- Public Health, Environmental and Occupational Health 3.7k
Countries citing papers authored by Frédéric Amant
This map shows the geographic impact of Frédéric Amant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Amant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Amant more than expected).
Fields of papers citing papers by Frédéric Amant
This network shows the impact of papers produced by Frédéric Amant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Amant. The network helps show where Frédéric Amant may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Amant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 686 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer Hit paper breakdown → | 2010 | 1942 |
| 2 | Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research Hit paper breakdown → | 2014 | 1415 |
| 3 | Endometrial cancer Hit paper breakdown → | 2005 | 1260 |
| 4 | ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up Hit paper breakdown → | 2015 | 1081 |
| 5 | ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer Hit paper breakdown → | 2015 | 617 |
| 6 | Interrogating open issues in cancer precision medicine with patient-derived xenografts Hit paper breakdown → | 2017 | 547 |
| 7 | Tumour hypoxia causes DNA hypermethylation by reducing TET activity Hit paper breakdown → | 2016 | 512 |
| 8 | ESHRE guideline: female fertility preservation† Hit paper breakdown → | 2020 | 502 |
| 9 | 2016 | 462 | |
| 10 | Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT Hit paper breakdown → | 2008 | 419 |
| 11 | Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines† Hit paper breakdown → | 2020 | 365 |
| 12 | 2017 | 358 | |
| 13 | 2009 | 340 | |
| 14 | 2009 | 338 | |
| 15 | 2011 | 333 | |
| 16 | Cancer of the corpus uteri Hit paper breakdown → | 2018 | 301 |
| 17 | 2006 | 291 | |
| 18 | 2011 | 291 | |
| 19 | 2012 | 290 | |
| 20 | 2014 | 277 |
About Frédéric Amant
Frédéric Amant is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Cancer Research, Oncology and Public Health, Environmental and Occupational Health, having authored 686 papers that have together received 33.1k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (181 papers), Ovarian cancer diagnosis and treatment (129 papers), Pregnancy and Medication Impact (65 papers), Breast Cancer Treatment Studies (59 papers), Uterine Myomas and Treatments (56 papers), Cancer Risks and Factors (44 papers), Family Support in Illness (39 papers) and Reproductive Biology and Fertility (27 papers). The work is most often cited by research in Obstetrics and Gynecology (8.8k citations), Reproductive Medicine (6.8k citations), Cancer Research (3.9k citations), Oncology (5.5k citations) and Public Health, Environmental and Occupational Health (3.7k citations). Frédéric Amant has collaborated with scholars based in Belgium, Netherlands and Italy. Frequent co-authors include Ignace B. Vergote, Patrick Neven, Dirk Timmerman, Kristel Van Calsteren, Philippe Moerman, Karin Leunen, Carien L. Creutzberg, Mansoor Raza Mirza, Erik Van Limbergen and Toon Van Gorp. Their work appears in journals such as International Journal of Gynecological Cancer, Gynecologic Oncology, Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.